References

1. Chievitz O, Hevesy G. Nature 1935; 136:754. In: Brucer M. A Chronology of Nuclear Medicine. St. Louis: Heritage Publications, 1990:222.

2. Brucer M. A Chronology of Nuclear Medicine. St. Louis: Heritage Publications, 1990:222.

3. Hevesy G, et al. Kgl Danske V Selsk 1937; 13:9. In: Brucer M. A Chronology of Nuclear Medicine. St. Louis: Heritage Publications, 1990:222.

4. Lawrence JH, et al. Radium 1940; 35:51. In: Brucer M. A Chronology of Nuclear Medicine. St. Louis: Heritage Publications, 1990:226.

5. Erf L, et al. Ann Int Med 1941; 15:487. In: Brucer M. A Chronology of Nuclear Medicine. St. Louis: Heritage Publications, 1990:258.

6. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc 2003; 78:174-194.

7. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood 2002; 100(13):4272-4290.

8. Tefferi A, Solberg LA Jr, Silverstein MN. A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000; 109:141-149.

9. EANM Procedure Guidelines for 32P therapy. Eur J Nucl Med 2003; 30:BP17-BP19.

10. Cember H. Section on Bremsstrahlung in Chapter 5: Interaction of radiation with matter. In: Cember, H. Introduction to Health Physics. 3rd ed. New York: McGraw-Hill, 1996:129-131.

11. Batchelor S. Section 15.6.3 Special techniques for specific radionuclides: Phophorus-32. In: Martin CJ, Sutton DG, eds. Practical Radiation Protection in Health Care. New York: Oxford University Press, 2002:253.

12. Castronovo FP Jr, McKusick KA, Strauss HW. The infiltrated radiopharmaceutical injection: Dosimetric considerations. Eur J Nucl Med 1988; 14:93-97.

0 0

Post a comment